Aptinyx

$3.66
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.05 (+1.39%) Today
$0.00 (0.00%) As of 1:00 AM UTC after-hours

Why Robinhood?

You can buy or sell Aptinyx and other stocks, options, and ETFs commission-free!

About APTX

Aptinyx Inc. Common Stock, also called Aptinyx, is a clinical stage biopharmaceutical company. It engages in the discovery, development, and and commercialization of transformative therapies for disorders of the brain and nervous system. Its product includes NYX-2925, NYX-783, NYX-458, and the AGN-241751 program. The company was founded by Norbert G. Riedel and Joseph R. Moskal in June 2015 and is headquartered in Evanston, IL. The listed name for APTX is Aptinyx Inc. Common Stock.

CEO
Norbert G. Riedel
Employees
43
Headquarters
Evanston, Illinois
Founded
2015
Market Cap
229.30M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
513.00K
High Today
$3.71
Low Today
$3.45
Open Price
$3.64
Volume
314.18K
52 Week High
$6.47
52 Week Low
$1.60

APTX Earnings

-$0.56
-$0.37
-$0.19
$0.00
Q2 FY19
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Estimated
— per share
Actual
Expected Mar 30, After Hours

You May Also Like

HYI
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure